Cargando…
Pharmacogenomics of Multiple Sclerosis: A Systematic Review
Background: Over the past two decades, various novel disease-modifying drugs for multiple sclerosis (MS) have been approved. However, there is high variability in the patient response to the available medications, which is hypothesized to be partly attributed to genetics. Objectives: To conduct a sy...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399303/ https://www.ncbi.nlm.nih.gov/pubmed/30863357 http://dx.doi.org/10.3389/fneur.2019.00134 |